ELIXINOL WELLNESS LIMITED (EXL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EXL - ELIXINOL WELLNESS LIMITED

FNArena Sector : Health & Nutrition
Year End: December
GICS Industry Group : Household & Personal Products
Debt/EBITDA: -0.22
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.004

01 Nov
2024

0.000

OPEN

$0.00

0.000

HIGH

$0.00

0

LOW

$0.00

OTHER COMPANIES IN THE SAME SECTOR
CLV . EBO . MCP . SIG .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-1.2
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx8.3 M
Book Value Per Share xxxxxxxxxxxxxxx0.8
Net Operating Cash Flow xxxxxxxxxxxxxxx-2.8 M
Net Profit Margin xxxxxxxxxxxxxxx-90.78 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-96.12 %
Return on Invested Capital xxxxxxxxxxxxxxx-90.28 %
Return on Assets xxxxxxxxxxxxxxx-59.59 %
Return on Equity xxxxxxxxxxxxxxx-96.12 %
Return on Total Capital xxxxxxxxxxxxxxx-68.74 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-2.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx0 M
Total Debt xxxxxxxxxxxxxxx1 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx1 M
Price To Book Value xxxxxxxxxxxxxxx1.18

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.0 M
Capex % of Sales xxxxxxxxxxxxxxx0.21 %
Cost of Goods Sold xxxxxxxxxxxxxxx10 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx5 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

EXL STOCK CHART